27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Horizon Therapeutics (NASDAQ:HZNP) reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Horizon Therapeutics missed estimated earnings by 20.74%, reporting an EPS of $1.07 versus an estimate of $1.35.
Revenue was up $43.86 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.14 which was followed by a 3.43% drop in the share price the next day.
Here's a look at Horizon Therapeutics's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | 1.20 | 1.34 | 1.54 | 0.88 |
EPS Actual | 1.34 | 1.41 | 1.75 | 1.62 |
Revenue Estimate | 874.41M | 995.87M | 979.41M | 685.03M |
Revenue Actual | 885.25M | 1.01B | 1.04B | 832.55M |
To track all earnings releases for Horizon Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!